A new report from the Congressional Research Service provides an extensive overview of the U.S. war in Afghanistan, and the choices that confront U.S. policy makers.
“The U.S. Government faces key strategic and operational decisions about its further engagement in the war in Afghanistan. These may include clarifying U.S. national interests in Afghanistan and the region; defining clear strategic objectives based on those interests; determining which diplomatic, economic, and military approaches to adopt, and what resources to commit to support those approaches; prioritizing ‘Afghanistan’ versus other national security imperatives; and helping marshal a coordinated application of international efforts.”
See “War in Afghanistan: Strategy, Military Operations, and Issues for Congress” (pdf), January 23, 2009.
Other noteworthy new reports from the Congressional Research Service include the following (all pdf).
“Homeland Security Intelligence: Perceptions, Statutory Definitions, and Approaches,” updated January 14, 2009.
“Israel and Hamas: Conflict in Gaza (2008-2009),” January 15, 2009.
“Comprehensive Nuclear-Test-Ban Treaty: Background and Current Developments,” updated January 28, 2009.
“The Special Inspector General (SIG) for the Troubled Assets Relief Program (TARP),” January 14, 2009.
“Amendments to the Foreign Intelligence Surveillance Act Set to Expire in 2009,” January 6, 2009.
Confirmation that the construction of the security perimeter and associated security infrastructure at RAF Lakenheath are still ongoing once again raises questions about whether U.S. nuclear weapons have already been deployed to the base.
Alaskans are sensibly pulling back from the vogue for bans and returning to a western tradition that has worked for more than half a century – one that welcomes innovation but also oversees it closely.
The strength of our nation’s data policy isn’t just in the rules we write, but in how effectively we translate those rules into a system that prioritizes the public good. Join us in this movement to design and build more resilient national data policies.
The human cost is measured in deaths. The financial cost is measured in the $52 billion taxpayers pay annually end stage renal disease – double NASA’s budget.